Learning Objectives
Upon completion of this activity, participants should be able to:
- Define the rationale for and the mechanism of action of targeted therapies in multiple tumor types
- Cite recent clinical trial data on agents targeting the HER family of receptor tyrosine kinases for the treatment of solid tumors
- Discuss results from clinical trials investigating the safety and efficacy of antiangiogenesis agents for the treatment of multiple tumor types
- Describe the role that bisphosphonates play in managing bone health in cancer patients
Topics covered include:
- Introduction
- Mechanisms of Targeted Therapies
- Established Targeted Therapies in the Adjuvant Setting
- Rationale for Targeting the HER Family of Receptors in the Adjuvant Setting
- Targeting the Angiogenic Switch
- Clinical Trials Targeting Angiogenesis in the Adjuvant Setting
- Targeting the Tumor Microenvironment with Bisphosphonates
- The Future of Targeted Therapy
Abstract